Statistics on Biotechnology Use  
Results by sector of operation
Company sector. Biotechnology results by main variables and no. of employees. 
Unidades: specified in variables

,Fewer than 250 employees,250 or more employees,Total,
No. of companies carrying out R&D in Biotechnology,1.010,69,1.078,
%Companies according to biotechnology used: Genetic code,34,49,35,
%Companies according to biotechnology used: Functional units,41,54,42,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,25,48,27,
%Companies according to biotechnology used: Bioprocesses,48,59,49,
%Companies according to biotechnology used: Sub-cellular organisms,7,12,8,
%Companies according to biotechnology used: Bio-computing,22,22,22,
%Companies according to biotechnology used: Nanobiotechnology,14,18,14,
%Companies according to biotechnology used: Other,12,8,12,
Companies in which biotechnology activities are: Main and/or exclusive,511,15,526,
Companies in which biotechnology activities are: A secondary line of business,155,18,173,
Companies in which biotechnology activities are: A tool necessary for production,344,35,379,
%Company by field(s) of ultimate application of biotechnology use: Human Health,48,50,48,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,21,5,20,
%Company by field(s) of ultimate application of biotechnology use: Food products,32,36,33,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,24,21,24,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,15,15,
%Company by field(s) of ultimate application of biotechnology use: Industry,14,6,14,
Personnel in R&D in biotechnology (no. of persons),7.849,2.342,10.191,
Personnel in R&D in biotechnology (no. of persons): Researchers,4.469,1.305,5.774,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,3.380,1.037,4.417,
Personnel in R&D in biotechnology (no. of persons): women,4.199,1.326,5.525,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.320,695,3.015,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,1.879,631,2.511,
Personnel in R&D in biotechnology (FTE),5.530,1,1.661,2,7.191,4,
Personnel in R&D in biotechnology (FTE): Researchers,3.333,943,6,4.276,6,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.197,1,717,6,2.914,7,
Personnel in R&D in biotechnology (FTE): women,3.061,924,4,3.985,4,
Personnel in R&D in biotechnology (FTE): (women) Researchers,1.742,1,491,9,2.234,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.318,9,432,5,1.751,4,
Internal expenditure on R&D (thousands of euros),441.736,136.435,578.171,
1) By nature of the expense: Current expenses,387.035,130.565,517.601,
1.1) Remuneration to researchers,158.420,55.335,213.755,
1.2) Remuneration to technicians and assistants,74.027,24.413,98.440,
1.3) Other current expenses,154.588,50.818,205.406,
2) By nature of the expense: Capital expenses,54.701,5.870,60.570,
2.1) Land and buildings,22.554,54,22.609,
2.2) Equipment and instruments,30.685,5.483,36.169,
2.3) Acquisition of specific R&D software,1.461,332,1.793,
1) By origin of the funds: National funds,379.550,108.064,487.615,
1.1) Own funds,249.390,81.068,330.459,
1.2) From companies,32.831,12.630,45.462,
1.3) Public Administration funds,53.162,13.028,66.189,
1.4) From Universities,25.148,.,25.148,
1.5) From non profit private institutions,19.019,1.338,20.357,
1) By origin of the funds: Foreign funds,62.186,28.371,90.556,
2.1) From EU programmes,18.782,2.150,20.932,
2.2) Other foreign funds,43.403,26.221,69.624,
Purchase of R&D services in biotechnology (thousands of euros),111.514,54.508,166.022,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,67.448,30.007,97.455,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,44.065,24.501,68.567,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,47,30,46,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,12,13,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,14,16,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,13,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,18,14,17,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,17,12,17,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,18,17,18,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,35,36,35,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,50,34,49,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,22,9,21,
% Companies that have requested biotechnology patents in Biotechnology,15,21,15,
Number of patents requested,451,75,526,
% Companies with income of an international origin related to biotechnological activities,26,4,19,1,26,
% Turnover representing income of an international origin related to biotechnological activities,6,5,0,8,1,4,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,51,6,76,3,63,8,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,48,4,23,7,36,2,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,85,6,97,7,91,6,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,1,4,0,5,0,9,
% Income of an international origin related with activities according to the classification: Operating source abroad,3,0,7,1,9,
% Income of an international origin related with activities according to the classification: Other,10,1,1,1,5,6,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute